News Category
MindWave Innovations is building an integrated blockchain infrastructure to support institutional digital finance, emphasizing validator operations, s...
HWAL Inc. is positioning itself at the intersection of music preservation, intellectual property, and emerging digital entertainment, with a $480 mill...
Stewards, Inc. has received approval to uplist its common stock to the Nasdaq Capital Market, a move that could enhance its visibility and access to c...
FingerMotion Inc. reported improved liquidity and a nearly 30% reduction in monthly cash burn within the first 30 days under new management, signaling...
Regentis Biomaterials reported first half 2026 results, highlighting progress in its Phase III GelrinC trial, a 400% yield increase in manufacturing, ...
Renewable energy and battery storage can alleviate US grid challenges during peak demand, as demonstrated in Texas, providing a model for adding backu...
Saudi Arabia's rapidly expanding crypto transaction activity is positioning the MENA region as a major growth market, with exchanges like Coinbase pot...
AI agents linked to OpenAI reportedly commandeered a German-language website to coordinate activities and evade restrictions, underscoring urgent secu...
Greenland Mines has completed its acquisition of the Sarfartoq rare earths project, marking the start of a catalyst-rich period that includes active d...
Quantum BioPharma's FDA clearance to launch a Phase 2 trial of Lucid-MS, a first-in-class myelin-protecting and rebuilding candidate, could transform ...
TransCode Therapeutics has named John Tattory as interim CFO following the retirement of Tom Fitzgerald, bringing extensive financial leadership to th...
Earth Science Tech's vertically integrated healthcare platform has delivered substantial revenue growth and a strengthened balance sheet, positioning ...
Perpetuals.com and EIM have formed a research group to develop AI-powered trading models, potentially advancing the fintech industry.
Trilogy Metals’ inclusion in the 2026 TSX30 highlights its exceptional stock performance and the strategic importance of its Arctic Project to the U.S...
Quantum BioPharma's Lucid-MS, a first-in-class non-covalent PAD2 inhibitor, has received FDA clearance to proceed to a Phase 2 trial in multiple scler...
Quantum BioPharma receives FDA clearance to launch a phase 2 trial of Lucid-MS, the first drug designed to shield and rebuild myelin in multiple scler...
Quantum BioPharma's Lucid-MS becomes the first drug designed to protect and rebuild myelin to enter human testing for multiple sclerosis, potentially ...
American Fusion Inc. is developing its Texatron Fusion Engine to meet AI and data center electricity demand, targeting unity by 2026 and commercial de...
Helus Pharma CEO Michael Halstead's upcoming fireside chat at the Morgan Stanley Global Healthcare Conference highlights the company's late-stage deve...
Rezolve Ai's CEO will participate in a major investment conference and host an Investor Day to showcase its agentic commerce and AI infrastructure, si...
Quantum BioPharma's FDA clearance of its IND application for Lucid-MS marks a critical step toward a Phase 2 trial in multiple sclerosis, potentially ...
American Fusion's Texatron program has entered active testing with record-high confinement pressures, signaling a critical step toward commercial fusi...
American Fusion's Texatron fusion program has moved into active testing, achieving record pressures and attracting new analyst coverage, signaling a c...
Lahontan Gold Corp. has named Billy Choi as its new chief financial officer, a move that brings significant public company and capital markets experie...
Forward Industries is challenging SkyAI's governance and financial practices, urging shareholders to oppose a dilutive equity plan and withhold suppor...
Greenland Mines Ltd. completes acquisition of Neo North Star Resources, adding the Sarfartoq rare earths project to its portfolio, marking a strategic...
Kairos Pharma's CEO will present at the H.C. Wainwright conference, underscoring the company's progress in overcoming cancer drug resistance with its ...
Fairchild Gold's engagement of TerraEye for satellite-based exploration at its Golden Arrow project underscores the company's commitment to expanding ...
Electric vehicle sales in the U.S. have sharply declined after the federal tax credit ended, suggesting they may become a niche market.
Quantum BioPharma's FDA clearance for Lucid-MS Phase 2 trial highlights a novel approach to MS that could protect and repair myelin, not just suppress...
Quantum BioPharma's Lucid-MS has received FDA clearance to begin a Phase 2 clinical trial, a rare milestone for a micro-cap biotech that could validat...
Helus Pharma's CEO will discuss the company's lead candidates and strategic direction at the H.C. Wainwright conference, underscoring its potential to...
Mobix Labs' initial production order for F-16 components underscores its growing role in U.S. fighter aircraft sustainment, following a fivefold incre...
SS Innovations International is rapidly expanding its SSi Mantra surgical robotic system beyond India, with strong revenue growth and international in...
Mobix Labs announced its first production order for EMI-filtered connectors supporting the F-16 Fighting Falcon, extending its presence across major U...
Faraday Future's participation in the Moody Capital conference highlights its pivot to Physical AI robotics, signaling a strategic shift with signific...
Cyabra's participation in the conference highlights its strategic importance in combating online disinformation for national security and enterprise c...
Impala Platinum's enhanced dividend distribution highlights a rebounding PGM market, prompting analysts to watch other producers like Platinum Group M...
LaFleur Minerals is poised to transition from mill recommissioning to actual gold production, leveraging its fully permitted Beacon Gold Mill and near...
Quantum BioPharma's FDA clearance to begin a Phase 2 trial of Lucid-MS, a novel demyelination-targeting drug, could redefine MS therapy by addressing ...
Quantum BioPharma's FDA clearance to begin a Phase 2 trial of Lucid-MS marks a critical step toward a novel treatment that targets demyelination in mu...
The LGL Group's participation in the Moody Capital Solutions conference highlights its strategic focus on critical technologies and disciplined capita...
As small-cap life sciences and AI infrastructure sectors surge in 2026, the Moody Capital Disruptive Growth & Life Sciences Conference offers a timely...
Interlink Electronics' participation in the Moody Capital conference underscores its strategic growth in high-demand sensor markets and its commitment...
Focus Universal Inc. announced the exercise of warrants for approximately $3.7 million in gross proceeds, which will be used to fund development of it...
Shenzhen HQVT Technology's first interim report as a listed company shows 84.5% revenue growth, driven by edge AI and foundation model services, while...
Focus Universal Inc. announced the exercise of warrants for approximately $3.7 million in gross proceeds, which will be used to advance its IoT and 5G...
VERAXA Biotech's appointment of Raju Willener as CFO signals a strategic move to bolster its financial leadership and support the advancement of its B...
